Thrombogenic potential of human coronary atherosclerotic plaques. 2001

D Ardissino, and P A Merlini, and K A Bauer, and E Bramucci, and M Ferrario, and R Coppola, and R Fetiveau, and S Lucreziotti, and R D Rosenberg, and P M Mannucci
Division of Cardiology, Ospedale Maggiore and University of Parma, Italy. ardis001@planet.it

Higher levels of tissue factor (the initiator of blood coagulation) have been found in coronary atherosclerotic plaques of patients with unstable coronary artery disease, but it is not established whether they are associated with a different thrombotic response to in vivo plaque rupture. In 40 patients undergoing directional coronary atherectomy, prothrombin fragment 1 + 2, a marker of thrombin generation, was measured in intracoronary blood samples obtained proximally and distally to the coronary atherosclerotic plaque before and after the procedure. Before the procedure, plasma prothrombin fragment 1 + 2 levels were significantly increased across the lesion in patients with unstable, but not in those with stable, coronary disease (unstable, median increase, 0.37 nM; range, -0.35-1.16 nM) (stable, median increase, -0.065 nM; range, -0.58-1.06 nM) (P =.0021). After plaque removal, an increase in prothrombin fragment 1 + 2 across the lesion was observed only in patients with unstable coronary disease (unstable, median increase, 0.25 nM; range, -1.04-4.9 nM) (stable, 0.01 nM; range, -0.48-3.59 nM) (P =.036)]. There was a correlation between the tissue factor content of the plaque and the increase in thrombin generation across the lesion (rho = 0.33; P =.038). The higher tissue factor content found in plaques obtained from patients with unstable coronary disease was associated with a local increase in thrombin generation, thus suggesting a link with the in vivo thrombogenicity of the plaque.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005260 Female Females
D006490 Hemostatics Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. Antihemorrhagic,Hemostatic,Antihemorrhagics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Ardissino, and P A Merlini, and K A Bauer, and E Bramucci, and M Ferrario, and R Coppola, and R Fetiveau, and S Lucreziotti, and R D Rosenberg, and P M Mannucci
February 2007, Journal of the American College of Cardiology,
D Ardissino, and P A Merlini, and K A Bauer, and E Bramucci, and M Ferrario, and R Coppola, and R Fetiveau, and S Lucreziotti, and R D Rosenberg, and P M Mannucci
October 1994, The American journal of pathology,
D Ardissino, and P A Merlini, and K A Bauer, and E Bramucci, and M Ferrario, and R Coppola, and R Fetiveau, and S Lucreziotti, and R D Rosenberg, and P M Mannucci
September 1985, Archives of environmental contamination and toxicology,
D Ardissino, and P A Merlini, and K A Bauer, and E Bramucci, and M Ferrario, and R Coppola, and R Fetiveau, and S Lucreziotti, and R D Rosenberg, and P M Mannucci
November 2009, Cardiology clinics,
D Ardissino, and P A Merlini, and K A Bauer, and E Bramucci, and M Ferrario, and R Coppola, and R Fetiveau, and S Lucreziotti, and R D Rosenberg, and P M Mannucci
May 2018, Scientific reports,
D Ardissino, and P A Merlini, and K A Bauer, and E Bramucci, and M Ferrario, and R Coppola, and R Fetiveau, and S Lucreziotti, and R D Rosenberg, and P M Mannucci
December 1989, Lancet (London, England),
D Ardissino, and P A Merlini, and K A Bauer, and E Bramucci, and M Ferrario, and R Coppola, and R Fetiveau, and S Lucreziotti, and R D Rosenberg, and P M Mannucci
June 2001, Archives des maladies du coeur et des vaisseaux,
D Ardissino, and P A Merlini, and K A Bauer, and E Bramucci, and M Ferrario, and R Coppola, and R Fetiveau, and S Lucreziotti, and R D Rosenberg, and P M Mannucci
June 2016, Nihon rinsho. Japanese journal of clinical medicine,
D Ardissino, and P A Merlini, and K A Bauer, and E Bramucci, and M Ferrario, and R Coppola, and R Fetiveau, and S Lucreziotti, and R D Rosenberg, and P M Mannucci
March 2006, Journal of the American College of Cardiology,
D Ardissino, and P A Merlini, and K A Bauer, and E Bramucci, and M Ferrario, and R Coppola, and R Fetiveau, and S Lucreziotti, and R D Rosenberg, and P M Mannucci
December 1988, British heart journal,
Copied contents to your clipboard!